Healthcare doesn’t slow down. Here’s what’s worth your attention this week: a trend, an insight, a tactic, and an opinion. Designed to start your week sharp, in the time it takes to drink your first cup of coffee.
Trend: Healthcare buyers are now vetting vendors through AI search before visiting a single website.
This isn’t a prediction; it’s already the default B2B behavior. Forrester’s 2026 Buyers’ Journey Survey of nearly 18,000 global business buyers found that generative AI and conversational search are now the most meaningful source of vendor research, outranking vendor websites, product experts, and sales representatives. The specific use cases are telling: buyers are using AI tools to research product information, compare vendors, and build internal business cases before engaging any vendor at all.
For B2B healthcare vendors, this means the shortlist is being assembled before the first outreach, demo, or touchpoint. Content that isn’t structured to answer specific buyer questions directly and authoritatively doesn’t show up, and what doesn’t show up doesn’t get considered.
Insight: Trigger-based outreach is outperforming standard prospecting by a wide margin.
Outreach timed to relevant account triggers: leadership changes, mergers, regulatory updates, new funding; is generating meetings at 3–4x the rate of standard cold outreach in B2B healthcare.
The triggers worth tracking in B2B healthcare:
- New C-suite or VP hire at a target account
- Health system merger or acquisition announcement
- CMS or state-level regulatory change affecting the buyer
- A competitor exiting the market or losing a contract
Success comes from combining account focus with timing. Build a list of priority accounts, track key organizational changes, and reach out quickly when a meaningful trigger occurs. Becker’s documented 359 health system executive leadership changes in the opening weeks of 2026 alone, highlighting the volume of high-value engagement opportunities available to teams with a structured trigger-based outreach strategy.
Tool/Tactic: Most B2B healthcare sellers have no idea who’s already researching them.
B2B buyers complete 70–80% of their research before contacting a vendor. Tools like Leadfeeder identify the companies visiting your website, revealing which organizations are researching your solutions and how often. A health system that has visited your revenue cycle solutions page multiple times is showing intent, not browsing casually.
In healthcare’s long sales cycles, identifying accounts while they are actively researching can create a meaningful advantage. By filtering website visitors to your ideal customer profile, routing high-intent activity into your CRM, and using tools like Apollo or LinkedIn Sales Navigator to find the right contacts, sales teams can engage prospects before they reach out to competitors.
Leadfeeder identifies companies rather than individuals, helping avoid HIPAA concerns while still requiring contact enrichment to reach the appropriate decision-maker. Free and paid plans are available.
Opinion: AEO is emerging as a core growth channel.
Most B2B healthcare marketers still view Answer Engine Optimization (AEO) as a content or SEO initiative, but the bigger opportunity is influencing buyers before they ever engage with a vendor. Gartner found that 45% of B2B buyers use generative AI during the purchasing process, often to research vendors and solutions.
When a health system VP asks ChatGPT to compare revenue cycle vendors or a benefits director uses Perplexity to evaluate TPAs, those interactions are early buying signals. The companies that appear in AI-generated answers are not there by chance. They have created structured, authoritative content that AI systems can easily find and cite.
In healthcare, where sales cycles often exceed a year and require more than 22 touchpoints, being visible before the first vendor interaction is not just a marketing tactic. It is a pipeline strategy.
Full breakdowns and deeper dives always at briviohealth.com.
